These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 28501028)
61. Castleman disease: an uncommon diagnosis in pediatrics. Vianna PM; Pastore PG; Cristofani L; Siqueira SAC; Aldred V; de Campos FPF; Zerbini MCN Autops Case Rep; 2012; 2(3):39-44. PubMed ID: 31528578 [TBL] [Abstract][Full Text] [Related]
62. Castleman disease: an update on classification and the spectrum of associated lesions. Cronin DM; Warnke RA Adv Anat Pathol; 2009 Jul; 16(4):236-46. PubMed ID: 19546611 [TBL] [Abstract][Full Text] [Related]
63. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions. Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319 [TBL] [Abstract][Full Text] [Related]
64. Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab. Iskandar A; Hwang A; Dasanu CA J Oncol Pharm Pract; 2019 Dec; 25(8):2016-2018. PubMed ID: 30486744 [TBL] [Abstract][Full Text] [Related]
65. Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report. Sugawara E; Sato T; Amasaki Y; Katsumata K Medicine (Baltimore); 2022 Feb; 101(8):e28941. PubMed ID: 35212301 [TBL] [Abstract][Full Text] [Related]
66. Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report. Otsuka M; Koga T; Sumiyoshi R; Okamoto M; Endo Y; Tsuji S; Takatani A; Shimizu T; Igawa T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Daisuke N; Kawakami A Medicine (Baltimore); 2019 May; 98(18):e15237. PubMed ID: 31045763 [TBL] [Abstract][Full Text] [Related]
67. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab. Plano F; Mancuso S; Camarda GM; Butera MG; Sucato G; Alecci G; Florena AM; Perrone S; Siragusa SM Chemotherapy; 2024; 69(1):35-39. PubMed ID: 37634492 [TBL] [Abstract][Full Text] [Related]
69. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution. Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093 [No Abstract] [Full Text] [Related]
70. Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease: A Spectrum of Disease? Drissi M; Dunlap R; Clayton L; Raess PW; Mengden Koon S; White K Am J Dermatopathol; 2022 Apr; 44(4):294-296. PubMed ID: 34966045 [TBL] [Abstract][Full Text] [Related]
72. Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy. Cohen PR; Nikanjam M; Kato S; Goodman AM; Kurzrock R Cureus; 2020 Jul; 12(7):e8967. PubMed ID: 32766009 [TBL] [Abstract][Full Text] [Related]
73. Budd-Chiari syndrome, a rare complication of multicentric Castleman disease: A case report. Song K; Li M Oncol Lett; 2015 May; 9(5):2153-2156. PubMed ID: 26137030 [TBL] [Abstract][Full Text] [Related]
79. Castleman disease in an HIV-infected patient with Kaposi sarcoma. Saif MW AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020 [TBL] [Abstract][Full Text] [Related]
80. Radiologic and Histopathologic Features in an Intracranial Localized Castleman Disease: A Case Report and Review of Literature. Escribano Paredes JB; Carrasco Moro R; López Gutiérrez M; Arias HP; García-Cosío M; García Madrona S; Nedkova Hristova V; Martínez Poles J; Francisco JBC Neurologist; 2019 Jan; 24(1):33-36. PubMed ID: 30586033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]